Interventions promoting adherence to cardiovascular medicines

International Journal of Clinical Pharmacy

Volumn 34, Issue 2, 2012, Pages 295-311

  Van Dalem, Judith ^a   Krass, Ines ^b   Aslani, Parisa ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adherence; Cardiovascular diseases; Community healthcare setting; Interventions; Primary care setting

Indexed keywords

CARDIOVASCULAR AGENT;

BEHAVIOR CHANGE; BIBLIOGRAPHIC DATABASE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; COMMUNITY CARE; CONGESTIVE HEART FAILURE; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MOTIVATION; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY PREVENTION; SELF REPORT; SYSTEMATIC REVIEW;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; COUNSELING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; MOTIVATION; ORGANIZATIONAL OBJECTIVES; PATIENT EDUCATION AS TOPIC; PROFESSIONAL-PATIENT RELATIONS; PROGRAM DEVELOPMENT; SOCIAL BEHAVIOR;

EID: 84862843057     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9607-5     Document Type: Review

References (51)

1. World Health Organization. Cardiovascular Diseases (CVDs) Fact Sheet No 317, September 2011. Available from: http://www.who.int/mediacentre/factsheets/ fs317/en/index.html. Accessed 26 Sept 2011.
2. World Health Organization. Adherence to long-term therapies: evidence for action. Generva: World Health Organization; 2003.
3. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23): 3028-35.
4. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med. 1980;303:1038-41.
5. Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, Ransohoff DF, Sindelar J. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990;336: 542-5.
6. Sabate E, Adherence to long-term therapies. 2003, Geneva: World Health Organization 110.
7. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333(7557):15.
8. Beta Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA. 1982;247:1707-14.
9. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev, 2010; (3) Art No. CD005182; ISSN 1464-780X. doi:10.1002/14651858. CD005182.pub4.
10. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev, 2010; (3) Art No CD004371; ISSN 1464-780X. doi:10.1002/14651858.CD004371.pub3.
11. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev, 2008; (2) Art No CD000011; ISSN 1464-780X. doi: 10.1002/14651858.CD000011.pub 3.
12. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540-50.
13. Schroeder K, Fahey T, Hollinghurst S, Peters TJ. Nurse-led adherence support in hypertension: a randomized controlled trial. Fam Pract. 2005;22(2):144-51.
14. Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, Lipp A, Daly C, Howe A, Hall R, Harvey I. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ. 2007;334(7603):1098.
15. Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-25.
16. Udelson JE, Pressler SJ, Sackner-Bernstein J, Massaro J, Or-dronneau P, Lukas MA, Hauptman PJ. Adherence with once daily versus twice daily carvedilol in patients with heart failure: the compliance and quality of life study comparing once-daily con-trolled-release carvedilol CR and twice-daily immediate-release carvedilol IR in patients with heart failure (CASPER) trial. J Card Fail, 2009; 15(5): 385-93.
17. Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9(5):404-11.
18. GESICA investigators. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ, 2005; 331(7514): 425.
19. Wakefield BJ, Holman JE, Ray A, Scherubel M, Burns TL, Kienzle MG, Rosenthal GE. Outcomes of a home telehealth intervention for patients with heart failure. J Telemed Telecare. 2009;15(1):46-50.
20. Pearce KA, Love MM, Shelton BJ, Schoenberg NE, Williamson MA, Barron MA, Houlihan JM. Cardiovascular risk education and social support (CaRESS): report of a randomized controlled trial from the Kentucky Ambulatory Network (KAN). J Am Board Fam Med. 2008;21(4):269-81.
21. Schectman G, Hiatt J, Hartz A. Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy. Ann Pharmacother. 1994;28(1):29-35.
22. Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counselling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharma-cotherapy. 2000;20(4):410-6.
23. Coull AJ, Taylor VH, Elton R, Murdoch PS, Hargreaves AD. A randomised controlled trial of senior Lay Health Mentoring in older people with ischaemic heart disease: the Braveheart Project. Age Ageing. 2004;33(4):348-54.
24. Saito I, Saruta T. Effect of education through a periodic newsletter on persistence with antihypertensive therapy. Hypertens Res. 2003;26(2):159-62.
25. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49(2):164-70.
26. De Castro SM, Fuchs FD, Santos MC, Maximiliano P, Gus M, Moreira LB, Ferreira MBC. Pharmaceutical care program for patients with uncontrolled hypertension. AJH. 2006;19(5): 528-33.
27. Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc (2003). 2008;48(1):58-63.
28. Hunt JS, Siemienczuk J, Touchette D, Payne N. Impact of educational mailing on the blood pressure of primary care patients with mild hypertension. J Gen Intern Med. 2004;19(9):925-30.
29. Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, Le-Blanc BH, Touchette D. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23(12): 1966-72.
30. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, Carey K. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hyper-tens. 1996;9(4 Pt 1):285-92.
31. Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, Richardson T, Phillips E, Spencer J, Allegrante JP. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21(10): 1137-43.
32. Mohammadi E, Abedi HA, Jalali F, Gofranipour F, Kazemnejad A. Evaluation of 'partnership care model' in the control of hypertension. Int J Nurs Pract. 2006;12(3):153-9.
33. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000; 20(11):1384-9.
34. Stromberg A, Dahlstrom U, Fridlund B. Computer-based education for patients with chronic heart failure. A randomised, controlled, multicentre trial of the effects on knowledge, compliance and quality of life. Patient Educ Couns. 2006;64(1-3): 128-35.
35. Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001;23(6):970-80.
36. Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm. 1995;52(20):2196-9.
37. Marquez Contreras E, Vegazo Garcia O, Claros NM, Gil Guillen V, de la Figuera von Wichmann M, Casado Martinez JJ, Fernandez R. Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETE-CUM-HTA study. Blood Press, 2005; 14(3): 151-8.
38. Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, Figueras M, Galera J, Serra A. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens, 2006; 24(1): 169-75.
39. Thomas PD, Miceli R. Evaluation of the "Know Your Health" program for type 2 diabetes mellitus and hypertension in a large employer group. Am J Manag Care, 2006; 12:SP33-9.
40. Johnson SS, Driskell MM, Johnson JL, Prochaska JM, Zwick W, Prochaska JO. Efficacy of a transtheoretical model-based expert system for antihypertensive adherence. Dis Manag. 2006;9(5): 291-301.
41. Barrios V, Escobar C, Navarro A, Calderón A, Ruilope LM. Antihypertensive effectiveness of lercanidipine administered using an electronic pillbox compared with usual care in a cohort of mild-to-moderately hypertensive patients: the ELECTRA study. Therapy. 2007;4(4):433-40.
42. Dusing R, Handrock R, Klebs S, Tousset E, Vrijens B. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens. 2009;27(4): 894-901.
43. Schmidt S, Sheikzadeh S, Beil B, Patten M, Stettin J. Acceptance of telemonitoring to enhance medication compliance in patients with chronic heart failure. Telemed J E Health. 2008;14(5): 426-33.
44. Patel BV, Leslie RS, Thiebaud P, Nichol MB, Tang SS, Solomon H, Honda D, Foody JM. Adherence with single-pill amlodipine/atorvastatin vs. a two-pill regimen. Vasc Health Risk Manag. 2008;4(3):673-81.
45. Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VM, Zhao XQ, Albers JJ, Knopp RH. Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol \100 mg/dl in patients with hyperlipidemia and coronary artery disease. Am J Cardiol. 1997; 80(2):111-5.
46. Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother. 2003;37(9):1186-93.
47. Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther. 1991;13(4):489-95.
48. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol. JAMA. 2006;296(21):2563-71.
49. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43(3):413-22.
50. Cook CL, Wade WE, Martin BC, Perri M 3rd. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc. 2005;45(2):151-9.
51. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7): 649-52.